Product Name
MOZOBIL INJECTION 24mg/1.2 ml vial
Product Overview
MOZOBIL Injection is a specialized medication designed to mobilize hematopoietic stem cells in patients undergoing autologous transplantation. It is primarily used in combination with granulocyte-colony stimulating factor (G-CSF) to enhance the collection of stem cells for transplantation procedures.
Key Features
- Active Ingredient: Plerixafor
- Concentration: 24mg/1.2 ml per vial
- Indication: Mobilization of hematopoietic stem cells
- Administration: Subcutaneous injection
- Compatibility: Used in conjunction with G-CSF
- Packaging: Sterile, single-use vial
Usage Instructions
MOZOBIL Injection is administered by a healthcare professional. The dosage and administration schedule are determined based on individual patient needs and in conjunction with G-CSF therapy. Patients should follow the guidance of their healthcare provider for optimal results.
Benefits
- Efficient mobilization of stem cells for collection
- Facilitates successful autologous transplantation
- Enhances patient outcomes in stem cell therapies
Precautions
Patients should inform their healthcare provider about any existing medical conditions, allergies, or medications they are taking prior to receiving MOZOBIL Injection. Regular monitoring by a healthcare professional is essential during the treatment process.
Side Effects
Common side effects may include nausea, fatigue, and injection site reactions. Patients are advised to report any severe or persistent adverse reactions to their healthcare provider immediately.
Storage Information
MOZOBIL Injection should be stored at controlled room temperature, away from direct light and moisture. Ensure that it is kept out of reach of children and not used beyond the expiration date indicated on the packaging.